Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 12, 2026.
CompletedNCT06538662
Ocular Redness · Eye Irritation
Phase 35 years - Not specifiedNewport Beach, California, United States +7 The purpose of this study is to assess the safety and efficacy of FID 123320 Ophthalmic Solution (Apraclonidine HCl 0.125%) compared to Vehicle for relieving redness of the eye due to minor eye irritations in pediatric and adult populations.
RecruitingNCT07243990
Postoperative Agitation · Emergence Delirium, Anesthesia
Not applicable6 years - 12 yearsSakarya, Turkey (Türkiye) Postoperative agitation is frequently observed in the pediatric patient group following general anesthesia. The exact cause of this agitation has not been clearly determined; however, it may be associated with various factors such as anesthesia depth…
Not yet recruitingNCT07847697
Healthy Participants
Phase 118 years - 50 yearsTianjin, China Phase Ia to evaluate the safety, tolerability, immunogenicity, and pharmacokinetics of SCTB10 following a single dose in healthy participants
Not yet recruitingNCT07929220
Early Pregnancy Loss · Missed Abortion · Miscarriage in First Trimester · Miscarriage, Missed
Not applicable18 years - Not specifiedLocation not listed This small pilot study will assess whether early pregnancy loss (miscarriage) can be treated in an outpatient clinic using hysteroscopy without anesthesia, how well patients tolerate the procedure, and what complications occur. Hysteroscopy uses a sm…
CompletedNCT06721494
Methamphetamine Intoxication · Methamphetamine Disorders · Methamphetamine Abuse
Phase 218 years - 55 yearsGlendale, California, United States The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infusion in otherwise healthy, non-treatment seeking participants with methamphetamine use disor…
RecruitingNCT06895473
Hematopoietic and Lymphatic System Neoplasm
Phase 218 years - Not specifiedPortland, Oregon, United States This phase II trial tests how well cytarabine (Ara-C), methotrexate, and hydrocortisone given between the spinal cord and the membranes that protect it (intrathecal \[IT\]) works in preventing high-grade immune effector-associated neurotoxicity syndr…
Active, not recruitingNCT07215624
Malignant Digestive System Neoplasm · Malignant Female Reproductive System Neoplasm · Malignant Genitourinary System Neoplasm
Observational18 years - Not specifiedKingman, Arizona, United States +84 This study evaluates the use of extended venous thromboembolism prophylaxis (ePPx) following abdominopelvic cancer surgery within the NCI Community Oncology Research Program (NCORP) network, targeting surgeons and surgical advanced practice providers…
CompletedNCT03531255
PNH
Phase 318 years - Not specifiedLos Angeles, California, United States +57 This is an Open-label, Non-Randomized, Multi-Center Extension Study. Eligible subjects will have previously completed a pegcetacoplan study.
Not yet recruitingNCT07927764
Head and Neck Cancer
Observational18 years - Not specifiedLocation not listed This is an observational, pharmacological, retrospective, multicenter study and involves a total of 4 enrolling centers. This study aims to demonstrate that, in real-world clinical practice, the survival of RAI-refractory patients treated with Lenvat…
Active, not recruitingNCT05317806
Plasminogen Activator Inhibitor-1 Deficiency · Cardiac Fibrosis
Phase 418 years - 65 yearsIndianapolis, Indiana, United States This study will evaluate the efficacy and safety of metformin, in patients 18-65 years of age with homozygous plasminogen activator inhibitor-1 (PAI-1) deficiency, with or without cardiac fibrosis, for a period of 60 months. The starting dose of metf…
Active, not recruitingNCT06716463
Ventilatory Failure · Hypoxemic Respiratory Failure · Weaning Failure · Respiratory
Observational18 years - Not specifiedToronto, Ontario, Canada The goal of this observational study is to assess the potential non-invasive tools (e.g. regional ventilation, respiratory muscle response, lung mechanic's parameters) to identify the risk of failure when using high flow nasal cannula (HFNC) or non-i…
Not yet recruitingNCT07927777
Locally Advanced Prostate Cancer
Phase 318 years - 99 yearsPadova, Italy/Padova, Italy +8 This study is designed to evaluate the efficacy of Relugolix for 3 months before radical prostatectomy + lymph node dissection followed by 6 months Relugolix versus radical prostatectomy + lymphnode dissection followed by 6 months Relugolix. Relugoli…
Retrieved from ClinicalTrials.gov: Nov 12, 2026. Overall study status may differ from a particular location’s status.
